Concepedia

Evaluation of Treatment Patterns and Survival among Patients with Diffuse Large B-Cell Lymphoma in the USA

Vicki A. Morrison, Yaping Shou, Jill A. Bell, Laurie Hamilton, Augustina Ogbonnaya, Aditya Raju, Kristin Hennenfent, Michael Eaddy, Aaron Galaznik

Future Oncology · 2019 · 32 citations · 13 references

DOI

Abstract

These results illustrate the need for new treatment options for patients unable to tolerate initial combination therapy and transplant-ineligible patients who require salvage therapy.

References

13

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

Cancer Management, Pathology, Cancer Registration +17

Cancer statistics, 2017

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 14.9K citations · Full text

Epidemiology Of Cancer, Population Health Sciences, Cancer Registration +21

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Michael Pfreundschuh, Lorenz Trümper, Anders Österborg et al. · The Lancet Oncology · 2006 · 2.1K citations

Hematological Malignancy, Lymphoid Neoplasia, Mabthera International Trial +7

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Lindsay M. Morton, Sophia Wang, Susan S. Devesa et al. · Blood · 2005 · 1.7K citations · Full text

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

Bertrand Coiffier, Catherine Thiéblemont, Éric Van Den Neste et al. · Blood · 2010 · 1.5K citations · Full text